5-OMe-UDP is a Potent and Selective P2Y6-Receptor Agonist

Journal of Medicinal Chemistry
2010.0

Abstract

P2Y nucleotide receptors (P2Y-Rs) play important physiological roles. However, most of the P2Y-R subtypes are still lacking potent and selective agonists and antagonists. Based on data mining analysis of binding interactions in 44 protein-uridine nucleos(t)ides complexes, we designed uracil nucleotides, substituted at the C5/C6 position. All C6-substituted derivatives were inactive at the P2Y(2,4,6)-Rs, while out of the C5-substituted analogues, only 5-OMe-UD(T)P showed activity. To rationalize the data, the ionization and conformation of these analogues were evaluated. The pK(a) values of most analogues substituted at the C5/C6 positions were unaltered compared to UTP (pK(a) 9.42), except for 5-F-UTP nucleotide (pK(a) 7.85). C6-substituted analogues adopt the syn or high-syn conformations, which are disfavored by the receptors, while 5-OMe-UD(T)P adopt the favored anti conformation. Furthermore, 5-OMe-UDP adopts the S sugar puckering, which is the conformation preferred by the P2Y(6)-R, but not the P2Y(2)- or P2Y(4)-Rs. 5-OMe-UDP fulfills the conformational and H-bonding requirements of P2Y(6)-R, thus, making a potent P2Y(6)-R agonist (EC(50) 0.08 microM), more than UDP (EC(50) 0.14 microM).

Knowledge Graph

Similar Paper

5-OMe-UDP is a Potent and Selective P2Y<sub>6</sub>-Receptor Agonist
Journal of Medicinal Chemistry 2010.0
Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub>Receptors
Journal of Medicinal Chemistry 2006.0
Structure−Activity Relationships of Uridine 5‘-Diphosphate Analogues at the Human P2Y<sub>6</sub>Receptor
Journal of Medicinal Chemistry 2006.0
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety
Bioorganic &amp; Medicinal Chemistry 2012.0
Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y<sub>6</sub> Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications
Journal of Medicinal Chemistry 2010.0
Structural Modifications of UMP, UDP, and UTP Leading to Subtype-Selective Agonists for P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors
Journal of Medicinal Chemistry 2011.0
Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
Journal of Medicinal Chemistry 2005.0
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists
Bioorganic &amp; Medicinal Chemistry 2008.0
Molecular Modeling of the Human P2Y<sub>2</sub> Receptor and Design of a Selective Agonist, 2‘-Amino-2‘-deoxy-2-thiouridine 5‘-Triphosphate
Journal of Medicinal Chemistry 2007.0
Structure−Activity Relationship of Uridine 5‘<b>-</b>Diphosphoglucose Analogues as Agonists of the Human P2Y<sub>14</sub> Receptor
Journal of Medicinal Chemistry 2007.0